|  | SF | GSP | GWB | P-value |
---|---|---|---|---|---|
 | Subjects (n) | Mean (range) | Mean (range) | Mean (range) |  |
Respiratory measurements | Â | ||||
eNO (ppb) | 19 | 22 (8–66) | 24 (9–61) | 19 (9–50) | 0.14 |
FVC (L) | 18 | 4.6 (3.3-6.8) | 4.7 (3.2-6.6) | 4.6 (3.3-6.5) | 0.96 |
FEV1 (L) | 18 | 3.8 (2.7-6.1) | 3.7 (2.6-5.7) | 3.8 (2.7-5.9) | 0.61 |
FEV1/FVC | 18 | 0.8 (0.6-0.9) | 0.9 (0.6-1.0) | 0.8 (0.6-1.0) | 0.44 |
Inflammatory measurements | |||||
CRP (ng/mL) | 17 | 30.1 (1.3-93.9) | 31.6 (0.9-149.3) | 53.2 (6.3-225.3) | 0.01* |
SAA (ng/mL) | 16 | 32.1 (6.1-93.9) | 29.8 (3.9-88.3) | 66.5 (9.4-355.1) | 0.08 |
sICAM (ng/mL) | 17 | 4.4 (2.2-8.1) | 4.5 (1.7-7.3) | 5.5 (2.5-8.8) | 0.01* |
IL-1β (pg/mL) | 21 | 3.7 (0.4-13.9) | 3.6 (0.2-17.7) | 3.0 (0.2-25.9) | 0.86 |
IL-8 (pg/mL) | 21 | 3.3 (0.8-15.3) | 2.4 (0.0-6.7) | 2.0 (0.8-5.0) | 0.13 |
Cortisol (ng/mL) | 10 | 0.4 (0.1-0.8) | 0.4 (0.2-0.6) | 0.3 (0.1-0.6) | 0.21 |
Blood pressure measurements | Â | ||||
SBP (mmHg) | 18 | 126 (106–166) | 124 (95–162) | 129 (109–155) | 0.27 |
DBP (mmHg) | 18 | 82 (66–103) | 82 (64–97) | 79 (56–99) | 0.21 |
PP (mmHg) | 18 | 43 (23–70) | 41 (19–65) | 46 (15–63) | 0.14 |
MAP (mmHg) | 18 | 97 (81–124) | 96 (76–119) | 96 (78–118) | 0.91 |
Heart rate variability measurements | |||||
SDNN (ms) | 18 | 77 (34–186) | 72 (28–164) | 75 (43–106) | 0.81 |
rMSSD (ms) | 18 | 41 (15–118) | 43 (13–161) | 48 (18–94) | 0.57 |
HF (ms2) | 18 | 1048 (23–6822) | 1054 (20–7261) | 1106 (52–4574) | 0.99 |
LF (ms2) | 18 | 1651 (407–4835) | 2483 (110–13518) | 1599 (250–4186) | 0.23 |
LF:HF | 18 | 5.0 (0.5-20.6) | 4.9 (0.2-13.1) | 3.0 (0.3-6.6) | 0.10 |
Heart rate (BPM) | 18 | 77.8 (58.9-94.9) | 78.9 (60.4-118.1) | 78.7 (62.2-128.0) | 0.94 |